Rethinking Therapeutic Misconception in Biobanking – Ambivalence Between Research and Treatment

  • Aaro Mikael Tupasela University of Copenhagen
  • Karoliina Snell University of Helsinki
  • Jose A. Cañada University of Helsinki

Abstract

Some authors have noted that in biobank re search participants may be guided by what is called therapeutic misconception, whereby participants attribute therapeutic intent to research procedures (Zawati and Knoppers, 2012; Lidz and Appelbaum, 2002).  This article argues that the notion of therapeutic misconception is increasingly less justified when evaluating biobanks. We present four examples taken from recent developments in biobanking to argue why the notion of therapeutic misconception is problematic in that biobanking practices are increasingly seeking to bridge research and treatment in different ways.  In this article we explore examples where the boundary between research and treatment become increasingly blurred, as well as the contextual significance of healthcare systems and their prevailing ideologies in healthcare management. We argue that biobanking practices are challenging the use value, as well as the philosophical and ethical underpinnings for the need to separate research and treatment, and thus the notion of therapeutic misconception in the first place. We call this tension between research and treatment ambivalent research advancement to highlight the difficulties that various actors have in managing such shifts within the healthcare-research systems.

Downloads

Download data is not yet available.

References

American College of Medical Genetics (2013) ACMG Recommendations For Reporting Of Incidental Findings In Clinical Exome And Genome Sequencing. Genetics in Medicine 15(7): 565-574.

Appelbaum, PS., Roth, LH. and Lidz, C. (1982) The Therapeutic Misconception: Informed Consent in Psychiatric Research. International Journal of Law and Psychiatry 5:319-329.

Aromaa, A., Launis, V. and Lötjonen, S. (2002) DNA-näytteet epidemiologisissa tutkimuksessa. DNA ja Epidemiologia-työryhmä. Helsinki: TUKIJA/ETENE. (DNA samples in epidemiological research)

Barbour, V. (2003) UK Biobank: A Project in Search of a Protocol? The Lancet 361: 1734-38.

Bledsoe, MJ et al. (2013) Return Of Research Results From Genomic Biobanks: Cost Matters. Genetics In Medicine 15: 103-105.

Burke, W., Evans, B. and Jarvik, GP. (2014) Return of Results: Ethical and Legal Distinctions Between Research and Clinical Care. American Journal of Medical Genetics 166C: 105-111.

Cambon-Thomsen, A., Rial-Sebbag, E. and Knoppers, B.M. (2007) Trends in Ethical and Legal Frameworks for the use of Human Biobanks. European Respiratory Journal 30(2): 373-382.

Curnutte, M. and Testa, G. (2012) Consuming Genomes: Scientific And Social Innovation In Direct-To-Consumer Genetic Testing. New Genetics and Society 31(2): 159-181.

Deschênes, M., Cardinal, G., Knoppers, B.M. and Glass, K.C. (2001) Human Genetic Research, DNA Banking and Consent: a Question of ‘Form’? Clinical Genetics 59: 221-239

Douglas, C. van El, C., Radstake, M., van Teeffelen, S. and Cornel, MC. (2012) The Politics of Representation in the Governance of Emergent ‘Secondary Use’ Biobanks: The Case of Dried Blood Spot Cards in the Netherlands. Studies in Ethics, Law and Technology 6(1): art.4.

Dresser, R. (2002) The Ubiquity and Utility of the Therapeutic Misconception. Social Philosophy and Policy 19(2): 271-294.

Eisemann, E. and Haga, SB. (1999) Handbook on Human Tissue Sources – A National Resource of Human Tissue Samples. RAND Monograph Report. Santa Monica: RAND.

Eriksson, S. (2004) Should Results From Genetic Research Be Returned To Research Subjects And Their Biological Relatives? TRAMES 8, 46–62.

European Commission (2013) Commission Staff Working Document - Use Of '-Omics' Technologies In The Development Of Personalised Medicine. Brussels: European Commission.

EU Workshop (2003) Biobanks for Health – Optimising the Use of European Biobanks and Health Registries for Research Relevant to Public Health and Combating Disease. Report and recommendations from an EU workshop held at Voksenåsen Hotel, Oslo 28-31 January.

Fernandez, CV., Kodish, E and Weijer, C. (2003) Informing Study Participants of Research Results: an ethical Imperative. IRB: a Review of Human Subjects Research 25(3): 12-19.

Frank, L. (2000) When an Entire Country is a Cohort. Science 287(5462): 2398-2399.

Green, et al. (2013) ACMG Recommendation for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Genetics in Medicine.

Halverson, CME. and Friedman Ross, L. (2012) Incidental Findings Of Therapeutic Misconception In Biobank-Based Research. Genetics in Medicine 14(6): 611-615.

Hansson, M.G., Dillner, J., Bartram, C.R., Carlsson, J. and Helgesson, G. (2006) Should Donors be Allowed to Give Broad Consent to Future Biobank Research? Lancet Oncology 7: 266-269.

Henderson, GE. et al. (2007) Clinical Trials and Medical Care: Defining the Therapeutic Misconception. PLoS Medicine 4(11): 1735-1738.

Hewitt, R. (2011) Biobanking: The Foundation of Personalised Medicine. Current Opinion in Oncology 12:112-119.

Hoeyer, K. (2008) The Ethics of Research Biobanking: A Critical Review of the Literature. Biotechnology and Genetic Engineering Reviews 25(1): 429-452.

Hoeyer, K. and Hogle, L. (2014) Informed Consent: The Politics of Intent and Practice in Medical Research Ethics*. Annual Review of Anthropology 43: 347-362.

McGowan, ML., Fishmanand, JR, and Lambrix, MA. (2010) Personal Genomics And Individual Identities: Motivations And Moral Imperatives Of Early Users. New Genetics And Society 29(3): 261-290.

Miller, F., Giacomini, M., Ahern, C., Robert, J. and de Laat, S. (2008) When Research Seems Like Clinical Care: a Qualitative Study of the Communication of Individual Cancer genetic Research results. BMC Medical Ethics 9(4).

National Bioethics Advisory Commission (2001) Ethical and Policy Issues in International Research: Clinical Trials in developing Countries. Available at https://bioethicsarchive.georgetown.edu/nbac/pubs.html. Accessed 8.4.2016.

Nobile, H., Vermeulen, E., Thys, K., Bergmann, M. and Borry, P (2013) Why Do Participants Enroll In Population Biobank Studies? A Systematic Literature Review. Expert Review of Molecular Diagnostics 13: 35-47.

Nørgaard-Pedersen, B. and Hougaard, DM. (2007) Storage Policies And Use Of The Danish Newborn Screening Biobank. Journal of Inherited Metabolic Diseases 30:530-536

OECD (2001) Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology. OECD, Paris.

Offit, K., Groeger, E., Turner, S., Wadsworth, E. and Weiser, M. (2004) The ‘Duty To Warn’ A Patient’s Family Members About Hereditary Disease Risk. Journal of American Medical Association 292, 1469–1473.

Prainsack, B. (2014) The Powers of Participatory Medicine. PLOS Biology 12(4).

Riegman, P. et al. (2008) Biobanking for Better Healthcare. Molecular Oncology 2: 213-222.

Simeon-Dubach, D. and Watson, P. (2014) Biobanking 3.0: Evidence based and Customer Focused Biobanking. Clinical Biochemistry 47: 300-308.

Skolbekken, J-A., Øystein Ursin, L., Solberg, B., Christensen, E. and Ytterhus, B.(2005) Not Worth The Paper It's Written On? Informed Consent And Biobank Research In A Norwegian Context. Critical Public Health 15(4): 335-347.

Smith, M. and Aufox, S. (2013) Biobanking: The Melding of Research with Clinical Care. Curr Genet Med Rep 1(2): 122-128.

Soini, S. (2013) Finland On A Road Towards A Modern Legal Biobanking Infrastructure. European Journal of Health Law 2013(3): 289-94.

Stjernschantz Forsberg, J., Hansson, MG and Eriksson, S. (2009) Changing Perspectives In Biobank Research: From Individual Rights To Concerns About Public Health Regarding The Return Of Results. European Journal of Human Genetics 17: 1544-1549

Strong, D.M. (2000) The US Navy Tissue Bank: 50 Years on the Cutting Edge. Cell and Tissue Banking 1: 9-16.

Tupasela, A. (2004) Ihmiskudoksen lääketieteellinen käyttö Suomessa [The medical use of human tissue in Finland]. Suomen lääkärilehti 4162-4164.

Tupasela, A. (2006) When Legal Worlds Collide: From Research to Treatment in Hereditary Cancer Prevention. European Journal of Cancer Care 15(3): 257-266.

Tupasela, A. (2010) Introduction: Consumer Medicine - From Passive Patients to Active Consumers. In Tupasela, A (ed.) Consumer Medicine. TemaNord 530. Nordic Council of Ministers, Copenhagen.

Tupasela, A. (2012) Governing Hereditary Disease in the Age of Autonomy. In Vermeulen, N., Tamminen, S. and Webster, A., (eds.) Bio-objects: Life in the 21st Century. Ashgate.

Tupasela, A. (2015) Tensions Between Policy and Practice in Finnish Biobank Legislation. Biopreservation and Biobanking 13(5): 379-381.

Tupasela, A. and Liede, S. (2016) State Responsibility And Accountability In Managing Big Data In Biobank Research - Tensions And Challenges In The Right Of Access To Data. In Mittelstadt, B. and Floridi, L. (eds). Ethics of Biomedical Big Data. Oxford University Publishing, Oxford. Forthcoming.

Viberg, J., Hansson, MG., Langenskiöld, S. and Segerdahl, P. (2014) Incidental Findings: The Time Is Not Yet Ripe For A Policy For Biobanks. European Journal of Human Genetics 22(4): 437-441.

Wadmann, S. and Hoeyer, K. (2014) Beyond the Ttherapeutic Misconception’: Research, Care and Moral Friction. BioSocieties 9 (1): 3-23.

Wallace, HM. (2005) The Development of UK Biobank: Excluding Scientific Controversy from Ethical Debate. Critical Public Health 15(4): 323-333.

Wallace, SE and Kent, A (2011) Population Biobanks And Returning Individual Research Results: Mission Impossible Or New Directions? Human Genetics, 130(3): 393-401.

Wilson, et al. (2014) The Challenge of Sustaining a Hospital-based Biobank and Core Molecular Laboratory: The Beaumont Experience. Biopreservation and Biobanking 12(5): 306-311.

Wolf, S., et al. (2012) Managing Incidental Findings And Research Results In Genomic Research Involving Biobanks And Archived Data Sets. Genetics in Medicine 14(4): 361-384.

Yuille, et al. (2008) Biobanking for Europe. Briefings in Bioinformatics, 9(1): 14-24.

Zawati, MH. and Knoppers, BM. (2012) International Normative Perspectives on the Return of Individual Research Results and Incidental Findings in Genomic Biobanks. Genetics in Medicine 14(4): 484-489.

Published
2017-02-15
Section
Research Papers